Legal Opinion
In re EpiPen Marketing, Sales Practices & Antitrust Litigation
United States Judicial Panel on Multidistrict Litigation
Decided August 3, 2017No. MDL No. 2785PublishedCited by 3 opinions
1Opinion of the Court
TRANSFER ORDER
SARAH S. VANCE, Chair
Before’ the Panel: * Plaintiffs in the Nordstrum action listed on Schedule A *1358and pending in the District of New Jersey-move under 28 U.S.C. § 1407 to centralize pretrial proceedings in this litigation in the District of New Jersey. This litigation consists of five actions pending in the Northern District of Illinois, the District of Kansas, the District of New Jersey, and the Western District of Washington, as listed on Schedule A. All of these actions involve allegations of anticompetitive conduct or unfair methods of competition by one or more Mylan…
2Cases cited4 opinions
- In re Gerber Probiotic Products Marketing & Sales Practices LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012
- In re Natrol, Inc., Glucosamine/Chondroitin Marketing & Sales Practices LitigationUnited States Judicial Panel on Multidistrict Litigation · 2014
- In re U.S. Office of Personnel Management Data Security Breach LitigationUnited States Judicial Panel on Multidistrict Litigation · 2015
- In re McCormick & Co.United States Judicial Panel on Multidistrict Litigation · 2015
3Cited by3 opinions
- Eichhorn-Burkhard v. Hill's Pet Nutrition, Inc. REMINDER TO COUNSEL -- This case is a tag-a-long action to 19-md-2887, MDL 2887 In Re: Hill's Pet Nutrition, Inc., Dog Food Products Liability LitigationDistrict Court, D. Kansas · 2020
- In re Epipen (Epinephrine Injection, USP) Employee Retirement Income Security Act (Erisa) LitigationUnited States Judicial Panel on Multidistrict Litigation · 2017
- KPH Healthcare Services, Inc. v. Mylan N.V.District Court, D. Kansas · 2022